You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科源製藥(301281.SZ):正在新建的注射劑智能製造項目、高端特色中間體及原料藥智能製造項目將採用信息化、智能化的運維管理模式
格隆匯 03-18 15:59

格隆匯3月18日丨科源製藥(301281.SZ)在投資者互動平台表示,公司致力於用數智醫藥守護生命健康,積極推進數智製造。公司沂南生產基地項目集智慧研發、智能製造、智慧園區、智能管理於一體,引進先進的生產設備和技術,實現全生產流程的智能化和數字化管理。公司正在新建的注射劑智能製造項目、高端特色中間體及原料藥智能製造項目將採用信息化、智能化的運維管理模式,充分利用智能製造、智能倉儲、智能物流、智能管理方式來提高生產效率,通過聚焦精益管理,大力推進數智賦能,實現生產效率和產品質量的雙提升,加快公司信息化和智能化的兩化融合。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account